ERIN SCHLECHTER: Open Payments
NPI 1477142123 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 22 payments from 13 companies in 2025. Trend: 2023 $534 · 2024 $443 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 3 | $99 |
| Calliditas Therapeutics US Inc. | 4 | $83 |
| Fresenius USA Marketing, Inc. | 3 | $64 |
| OPKO Pharmaceuticals, LLC | 3 | $58 |
| Amgen Inc. | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
Products named: TARPEYO, VELPHORO, RAYALDEE, KRYSTEXXA, ULTOMIRIS, Kerendia, JYNARQUE, BEXSERO.
Industry payments across FL — which companies pay providers there.
